Fitzgerald, R. C.
December 2006
Gut;Dec2006, Vol. 55 Issue 12, p1810
Academic Journal
The article reports on Barrett's esophageal stem cells molecular basis that is required to develop an effective clinical management trials. A description of the development of gastro-oesophageal reflux disease is provided. It suggests a different conceptual framework for Barrett's-associated cancer, and for the identification of its associated risks and treatment.


Related Articles

  • Assessment of reflux symptom severity: methodological options and their attributes. Bytzer, P. // Gut;May2004 Supplement 4, Vol. 53, piv28 

    Despite major advances in our understanding of reflux disease, the management of this disorder still presents many challenges. Reduction of heartburn is the most readily apparent objective for the patient with reflux disease. Thus the ability to measure heartburn accurately is of fundamental...

  • Nissen fundoplication improves gastric myoelectrical activity characteristics and symptoms in gastroesophageal reflux patients: evaluation in transcutaneous electrogastrography. Wiesław, Tarnowski; Adam, Kiciak; Artur, Binda; Lech, Baczuk; Krzysztof, Bielecki // Surgical Endoscopy;Jan2008, Vol. 22 Issue 1, p134 

    Gastric myoelectrical activity disorders play an essential role in the pathophysiology of gastroesophageal reflux disease (GERD), although little is known about gastric motility following surgical treatment of the disease. The aim of present study was to analyze the impact of Nissen...

  • Whither surgery in the treatment of gastroesophageal reflux disease (GERD)?  // CMAJ: Canadian Medical Association Journal;1/20/2004, Vol. 170 Issue 2, p219 

    Provides information on gastroesophageal reflux disease (GERD), a risk factor for esophageal cancer. Drugs that are highly effective in the treatment of GERD; Example of surgical antireflux procedure for GERD; Important trends in therapeutic approaches to GERD.

  • All PPIs equivalent for treatment of GERD.  // Journal of Family Practice;Dec2005, Vol. 54 Issue 12, p1024 

    This article cites a research study, which examines the differences between proton pump inhibitors (PPIs) for the treatment of gastroesophageal reflux disease (GERD). This study is in form of a meta-analysis, which identified all double-blinded randomized controlled trials comparing one PPI with...

  • Lansoprazole Heals Erosive Reflux Esophagitis Resistant to Histamine H2-Receptor Antagonist Therapy. Sontag, Stephen J.; Kogut, David G.; Fleischmann, Roy; Campbell, Donald R.; Richter, Joel; Robinson, Malcolm; McFarland, Miles; Sabesin, Seymour; Lehman, Glen A.; Castell, Donald // American Journal of Gastroenterology;Mar1997, Vol. 92 Issue 3, p429 

    Purpose: We conducted a randomized, double-blind, multicenter clinical trial to determine whether lansoprazole was superior to continued therapy with histamine H2-receptor antagonist therapy in healing erosive reflux esophagitis. Methods: Investigators from nine medical centers enrolled 159...

  • Oral Pantoprazole for Erosive Esophagitis: A Placebo-Controlled, Randomized Clinical Trial. Richter, Joel E.; Bochenek, Wieslaw // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3071 

    OBJECTIVES: The aim of this dose-response study was to compare the effectiveness of 10 mg, 20 mg, and 40 mg of pantoprazole with that of placebo tablets in the healing and symptom relief of gastroesophageal reflux disease associated with erosive esophagitis, and to determine the optimal dose....

  • Low-dose omeprazole for erosive esophagitis. Epling, John; Taylor, Harry // Journal of Family Practice;Feb1999, Vol. 48 Issue 2, p93 

    The article cites a research study that investigates whether low-dose omeprazole safe and effective in preventing recurrence of disease in patients with endoscopically diagnosed erosive esophagitis. A meta-analysis of long-term omeprazole trials found both 10 and 20 mg per day omeprazole...

  • Standardization of Surgical Technique in Antireflux Surgery: The LOTUS Trial Experience. Attwood, Stephen E. A.; Lundell, Lars; Ell, Christian; Galmiche, Jean-Paul; Hatlebakk, Jan; Fiocca, Roberto; Lind, Tore; Eklund, Stefan; Junghard, Ola // World Journal of Surgery;Jun2008, Vol. 32 Issue 6, p995 

    To date, it has been difficult to compare medical therapy for gastroesophageal reflux disease with that of surgical management from a scientific viewpoint, mainly because of the lack of standardization of the operative technique. This study was designed to identify a methodology for...

  • Endolumenal therapies for gastroesophageal reflux disease: are they dead? Pearl, Jonathan P.; Marks, Jeffrey M. // Surgical Endoscopy;Jan2007, Vol. 21 Issue 1, p1 

    The article presents an overview on endolumenal therapies for gastroesophageal reflux disease (GERD). It cites the series of specific criticisms and issues concerning the endolumenal therapies for GERD. Various case studies and research conducted are also mentioned in the article. It was found...


Read the Article


Sign out of this library

Other Topics